MANILA, Philippines — The Department of Science and Technology (DOST) will push through with the clinical trials of ivermectin for human use against COVID-19 amid opposition from some medical groups.
“It doesn’t change our position. The fact that we are doing research means that we want to answer the question of whether it will be of benefit to Filipino patients,” said Dr. Jaime Montoya, executive director of the DOST-Philippine Council for Health Research and Development, in an interview on ANC’s Headstart.
Montoya defended the move from critics saying that while similar trials have been done in other countries, the tests will show whether there will be different results on …
Keep on reading: DOST to proceed with ivermectin trials, urges critics to have ‘open mind’